Otsuka Holdings Co., Ltd. (OTSKY)
| Market Cap | 29.45B |
| Revenue (ttm) | 15.84B |
| Net Income (ttm) | 1.06B |
| Shares Out | n/a |
| EPS (ttm) | 1.95 |
| PE Ratio | 27.84 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,271 |
| Open | 27.22 |
| Previous Close | 27.09 |
| Day's Range | 27.22 - 27.31 |
| 52-Week Range | 17.10 - 32.41 |
| Beta | 0.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 14, 2025 |
About Otsuka Holdings
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr... [Read more]
Financial Performance
In 2023, Otsuka Holdings's revenue was 2.02 trillion, an increase of 16.14% compared to the previous year's 1.74 trillion. Earnings were 121.62 billion, a decrease of -9.18%.
Financial numbers in JPY Financial StatementsNews
Otsuka Holdings Co., Ltd. reports Q3 results
Otsuka Holdings Co., Ltd. reported a significant increase in revenue and profit for the nine-month period ended September 30.
Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific
Otsuka Holdings Co. is considering options for its holding in Hong Kong-listed MicroPort Scientific Corp., including selling its stake in the medical device maker, according to people familiar with th...